Diabetes Intervention Involving Person-centred Nutritional Education
The overall objective for this project is to evaluate the effects of a person-centred education intervention to promote a healthy, sustainable Nordic diet compared with the current practice of providing short dietary information on health outcomes of adults with Type 1 diabetes. The study will measure the intervention'
| Condition(s) | Diabetes Type 1 |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The overall objective for this project is to evaluate the effects of a person-centred education intervention to promote a healthy, sustainable Nordic diet compared with the current practice of providing short dietary information on health outcomes of adults with Type 1 diabetes. The study will measure the intervention's impact on blood glucose levels, blood lipids, blood pressure, and adherence to a sustainable and healthy Nordic diet. The main question the trial aims to answer is: Does a person-centred nutritional education have an impact on glucose time in range for adults with Type 1 diabetes, compared with short dietary information? The participants will: * Attend either a person-centred nutrition education (intervention) or receive short dietary information (control group). * Wear the |
| Who can participate | Inclusion Criteria: * Type 1 Diabetes. * Diabetes duration for more than 12 months at screening. * Adults 18 years or older. * HbA1c more than 57mmol/mol. * Use of continuous glucose monitoring (CGM) sensor for more than three months at screening and during the study period. * Use of basal and bolus insulin regimen for more than three months at screening and during the study period. * Written Informed Consent. Exclusion Criteria: * Women of childbearing potential: ongoing pregnancy or planned pregnancy during the study period. * Cognitive impairment or other disease that study physician find non-compatible with participation. * Planned change in glucose lowering treatment during study period (change of mealtime insulin analogue with same pharmacodynamic profile allowed). * Planned change o |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Umeå University |
| Locations | Enköping, Uppland, Sweden |
| Start date | 2025-09-01 |
| NCT ID | NCT07258758 |
| Official listing | https://clinicaltrials.gov/study/NCT07258758 |